Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Stomach Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Appendiceal Neoplasms 1

Interventions

Ifosfamide 30 Methotrexate 29 Doxorubicin 26 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 Specimen Handling 10 cabozantinib 9 apatinib 9 X-Rays 9 Carboplatin 9 fludarabine 8 Radiotherapy 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Drug Therapy 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Phantoms, Imaging 7 Biopsy 7 mifamurtide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Pafolacianine × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡